Which university are you at? <a href=" http://www.playinnovation.co.uk/canadian-nexium.pdf ">nexium backorder</a> Yancopoulos said Regeneron and Sanofi hope to seek regulatory approvals by late 2015 for their drug, for use by itself and with statins, after data from the remaining 11 late-stage trials of alirocumab are released. An estimated 23,000 patients are being studied in the various Phase III trials.